Mitochondrial dysfunction and Alzheimer's disease: New developments

Journal of Alzheimer's Disease

Volumn 9, Issue 2, 2006, Pages 111-117

  Mancuso, Michelangelo ^a   Siciliano, Gabriele ^a   Filosto, Massimiliano ^a   Murri, Luigi ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Alzheimer's disease; Mitochondria; mtDNA; Neurodegeneration

Indexed keywords

MITOCHONDRIAL PROTEIN; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; BIOENERGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA POLYMORPHISM; DNA REPAIR; DNA SEQUENCE; ENERGY METABOLISM; GENE EXPRESSION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; OXIDATIVE STRESS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SOMATIC MUTATION;

EID: 33746067845     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9203     Document Type: Review

References (49)

1. H.K. Anandatheerthavarada, G. Biswas, M.A. Robin and N.G. Avadhani, Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells, J Cell Biol 161 (2003), 41-54.
2. M.F. Beal, Mitochondria take center stage in aging and neurodegeneration, Ann Neurol 58 (2005), 495-505.
3. E. Bonilla, K. Tanji, M. Hirano, T.H. Vu, S. DiMauro and E.A. Schon, Mitochondrial involvement in Alzheimer's disease, Biochim Biophys Acta 1410 (1999), 171-182.
4. 0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease, Neurobiol Aging 23 (2002), 371-376.
5. P. Bubber, V. Haroutunian, G. Fisch, J.P. Blass and G.E. Gibson, Mitochondrial abnormalities in Alzheimer brain: mechanistic implications, Ann Neurol 57 (2005), 695-703.
6. L. Canevari, J.B. Clark and T.E. Bates, Beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria, FEBS Lett 457 (1999), 131-134.
7. S.M. Cardoso, M.T. Proenca, S. Santos, I. Santana and C.R. Oliveira, Cytochrome c oxidase is decreased in Alzheimer's disease platelets, Neurobiol Aging 25 (2004), 105-110.
8. S.M. Cardoso, I. Santana, R.H. Swerdlow and C.R. Oliveira, Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity, J Neurochem 89 (2004), 1417-1426.
9. G. Carrieri, M. Bonafe, M. De Luca, G. Rose, O. Varcasia, A. Bruni, R. Maletta, B. Nacmias, S. Sorbi, F. Corsonello, E. Feraco, K.F. Andreev, A.I. Yashin, C. Franceschi and G. De Benedictis, Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease, Hum Genet 108 (2001), 194-198.
10. P.F. Chinnery, G.A. Taylor, N. Howell, R.M. Andrews, C.M. Morris, R.W. Taylor, I.G. McKeith, R.H. Perry, J.A. Edwardson and D.M. Turnbull, Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies, Neurology 55 (2000), 302-304.
11. P.F. Chinnery, G.A. Taylor, N. Howell, D.T. Brown, T.J. Parsons and D.M. Turnbull, Point mutations of the mtDNA control region in normal and neurodegenerative human brains, Am J Hum Genet 68 (2001), 529-532.
12. M. Corral-Debrinski, T. Horton, M.T. Lott, J.M. Shoffner, A.C. McKee, M.F. Beal, B.H. Graham and D.C. Wallace, Marked changes in mitochondrial DNA deletion levels in Alzheimer brains, Genomics 23 (1994), 471-476.
13. P.E. Coskun, M.F. Beal and D.C. Wallace, Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication, Proc Natl Acad Sci USA 101 (2004), 10726-10731.
14. S. Craft, S. Asthana, G. Schellenberg, L. Baker, M. Cherrier, A.A. Boyt, R.N. Martins, M. Raskind, E. Peskind and S. Plymate, Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype, Ann N Y Acad Sci 903 (2000), 222-228.
15. P.J. Crouch, R. Blake, J.A. Duce, G.D. Ciccotosto, Q.X. Li, K.J. Barnham, C.C. Curtain, R.A. Cherny, R. Cappai, T. Dyrks, C.L. Masters and I.A. Trounce, Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42, J Neurosci 25 (2005), 672-679.
16. D. Curti, F. Rognoni, L. Gasparini, A. Cattaneo, M. Paolillo, M. Racchi, L. Zani, A. Bianchetti, M. Trabucchi, S. Bergamaschi and S. Govoni, Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients, Neurosci Lett 236 (1997), 13-16.
17. D.G. Davis, F.A. Schmitt, D.R. Wekstein and W.R. Markesbery, Alzheimer neuropathologic alterations in aged cognitively normal subjects, J Neuropath Exp Neurol 58 (1999), 376-388.
18. S. DiMauro and E.A. Schon, Mitochondrial respiratory-chain diseases. Mitochondrial respiratory-chain diseases, N Engl J Med 348 (2003), 2656-2668.
19. J. Drake, C.D. Link and D.A. Butterfield, Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model, Neurobiol Aging 24 (2003), 415-420.
20. J.L. Elson, C. Herrnstadt, G. Preston, L. Thal, C.M. Morris, J.A. Edwardson, M.F. Beal, D.M. Turnbull and N. Howell, Does the mitochondrial genome play a role in the etiology of Alzheimer's disease? Hum Genet 12 (2006), 1-14.
21. D. Gabuzda, J. Busciglio, L.B. Chen, P. Matsudaira and B.A. Yankner, Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative, J Biol Chem 269 (1994), 13623-13628.
22. G.E. Gibson, V. Haroutunian, H. Zhang, L.C. Park, Q. Shi, M. Lesser, R.C. Mohs, R.K. Sheu and J.P. Blass, Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype, Ann Neurol 48 (2000), 297-303.
23. C.A. Hansson, S. Frykman, M.R. Farmery et al., Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria, J Biol Chem 279 (2004), 51654-51660.
24. S.M. Khan, D.S. Cassarino, N.N. Abramova, P.M. Keeney, M.K. Borland, P.A. Trimmer, C.T. Krebs, J.C. Bennett, J.K. Parks, R.H. Swerdlow, W.D. Parker, Jr. and J.P. Bennett, Jr., Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways, Ann Neurol 48 (2000), 148-155.
25. M.P. King and G. Attardi, Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation, Science 246 (1989), 500-503.
26. S.J. Kish, C. Bergeron, A. Rajput, S. Dozic, F. Mastrogiacomo, L.J. Chang, J.M. Wilson, L.M. DiStefano and J.N. Nobrega, Brain cytochrome oxidase in Alzheimer's disease, J Neurochem 59 (1992), 776-779.
27. R.M. Kluck, E. Bossy-Wetzel, D.R. Green and D.D. Newmeyer, The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis, Science 275 (1997), 1132-1136.
28. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan and H. Wu, ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease, Science 304 (2004), 448-452.
29. M. Mancuso, M. Filosto, F. Bosetti, R. Ceravolo, A. Rocchi, G. Tognoni, M.L. Manca, G. Solaini, G. Siciliano and L. Murri, Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease, Exp Neurol 182 (2003), 421-426.
30. I. Maurer, S. Zierz and H.J. Moller, A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients, Neurobiol Aging 21 (2000), 455-462.
31. Y. Michikawa, F. Mazzucchelli, N. Bresolin, G. Scarlato and G. Attardi, Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication, Science 286 (1999), 774-779.
32. A. Mudher and S. Lovestone, Alzheimer's disease - do tauists and baptists finally shake hands? Trends Neurosci 25 (2000), 22-26.
33. E.M. Mutisya, A.C. Bowling and M.F. Beal, Cortical cytochrome oxidase activity is reduced in Alzheimer's disease, J Neurochem 63 (1994), 2179-2184.
34. A.K. Niemi, J.S. Moilanen, M. Tanaka, A. Hervonen, M. Hurme, T. Lehtimaki, Y. Arai, N. Hirose and K. Majamaa, A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects, Eur J Hum Genet 13 (2005), 166-170.
35. Y. Ohyagi, T. Yamada, K. Nishioka, N.J. Clarke, A.J. Tomlinson, S. Naylor, Y. Nakabeppu, J. Kira and S.G. Younkin, Selective increase in cellular A beta 42 is related to apoptosis but not necrosis, Neuroreport 11 (2000), 167-171.
36. W.D. Parker, Jr., C.M. Filley and J.K. Parks, Cytochrome oxidase deficiency in Alzheimer's disease, Neurology 40 (1990), 1302-1303.
37. J.M. Shoffner, M.D. Brown, A. Torroni, M.T. Lott, M.F. Cabell, S.S. Mirra, M.F Beal, C.-C. Yang, M. Gearing, R. Salvo, R.L. Watts, J.L. Juncos, L.A. Hansen, B.J. Crain, M. Fayad, C.L. Reckord and D.C. Wallace, Mitochondrial DNA variants observed in Alzheimer disease and parkinson disease patients, Genomics 17 (1993), 171-184.
38. S.A. Simonian and B.T. Hyman, Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation, J Neuropathol Exp Neurol 53 (1994), 508-512.
39. G.W. Small, J.C. Mazziotta, M.T. Collins, L.R. Baxter, M.E. Phelps, M.A. Mandelkern, A. Kaplan, A. La Rue, C.F. Adamson and L. Chang, Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease, JAMA 273 (1995), 942-947.
40. S. Sorbi, E.D. Bird and J.P. Blass, Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain, Ann Neurol 13 (1983), 72-78.
41. R.H. Swerdlow and S.M. Khan, A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease, Med Hypotheses 63 (2004), 8-20.
42. R.H. Swerdlow, J.K. Parks, D.S. Cassarino, D.J. Maguire, R.S. Maguire, J.P. Bennett, Jr., R.E. Davis and W.D. Parker, Jr., Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 49 (1997), 918-925.
43. 1 ATP-synthase and mitochondrial Na+/Ca+2 exchange are reduced in Alzheimer's disease cybrids, Mitochondrion 5 (2005), 109-119.
44. P.A. Trimmer, P.M. Keeney, M.K. Borland, F.A. Simon, J. Almeida, R.H. Swerdlow, J.P. Parks, W.D. Parker, Jr. and J.P. Bennett, Jr., Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture, Neurobiol Dis 15 (2004), 29-39.
45. P.A. Trimmer and M.K. Borland, Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement, Antioxid Redox Signal 7 (2005), 1101-1109.
46. J.M. Van der Walt, Y.A. Dementieva, E.R. Martin, W.K. Scott, K.K. Nicodemus, C.C. Kroner, K.A. Welsh-Bohmer, A.M. Saunders, A.D. Roses, G.W. Small, D.E. Schmechel, P. Murali Doraiswamy, J.R. Gilbert, J.L. Haines, J.M. Vance and M.A. Pericak-Vance, Analysis of European mitochondrial haplogroups with Alzheimer disease risk, Neurosci Lett 365 (2004), 28-32.
47. Y. Wang, Y. Michikawa, C. Mallidis, Y. Bai, L. Woodhouse, K.E. Yarasheski, C.A. Miller, V. Askanas, W.K. Engel, S. Bhasin and G. Attardi, Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication, Proc Natl Acad Sci USA 98 (2001), 4022-4027.
48. M. Wong-Riley, P. Antuono, K.C. Ho, R. Egan, R. Hevner, W. Liebl, Z. Huang, R. Rachel and J. Jones, Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems, Vision Res 37 (1997), 3593-3608.
49. J. Zhang, J. Asin-Cayuela, J. Fish, Y. Michikawa, M. Bonafe, F. Olivieri, G. Passarino, G. De Benedictis, C. Franceschi and G. Attardi, Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes, Proc Natl Acad Sci USA 100 (2003), 1116-1121.